Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
XCGORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCGENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCGNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DT.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DT.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCAORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.77 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.77 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.77 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.77 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.53 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used